Who is sponsoring NCT04517786?

NCT04517786 is sponsored by iSTAR Medical.

What drugs are being tested in NCT04517786?

Interventions in NCT04517786: MINIject CS627 implant.

What condition does NCT04517786 study?

NCT04517786 studies Glaucoma, Open-Angle Glaucoma Eye.

Is NCT04517786 still recruiting?

NCT04517786 is currently status unknown. Last updated 3 May 2023.

Last reviewed 2023-05-03 · How we verify

NCT04517786

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

MINIject (MINI SO627) in Patients With Open Angle Glaucoma Using Single Operator Delivery Tool

Status unknown NA Last updated 3 May 2023

What this trial tests

NA trial testing MINIject CS627 implant in Glaucoma, Open-Angle Glaucoma Eye in 21 participants. Status unknown.

Timeline

15 January 2021

Primary endpoint
16 May 2022

31 December 2023

Quick facts

Lead sponsor	iSTAR Medical
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	21
Start date	15 January 2021
Primary completion	16 May 2022
Estimated completion	31 December 2023
Sites	2 locations across Panama, India

Drugs / interventions tested

MINIject CS627 implant

Conditions studied

Glaucoma, Open-Angle Glaucoma Eye — all drugs for Glaucoma, Open-Angle Glaucoma Eye →

Sponsor

iSTAR Medical

Who can join

18 and older, any sex, with Glaucoma, Open-Angle Glaucoma Eye. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study will assess safety and performance in patients with open-angle glaucoma uncontrolled by topical hypotensive medications who had previously been implanted with a MINIject glaucoma implant.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of MINIject CS627 implant

Trials testing the same drug.

NCT03996200 — MINIject in Patients With Open Angle Glaucoma Using Single Operator Delivery Tool · NA · completed

Other iSTAR Medical trials

Trials by the same sponsor.

NCT05269680 — STAR-LIFE: a Post-market Registry on MINIject · recruiting
NCT03996200 — MINIject in Patients With Open Angle Glaucoma Using Single Operator Delivery Tool · NA · completed
NCT03624361 — MINIject Glaucoma Implant in European Patients · NA · completed
NCT03374553 — MINIject 636 in Patients With Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications · NA · completed
NCT03193736 — MINIject in Patients With Open Angle Glaucoma Uncontrolled by Topical Hypotensive Medications · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04517786 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by iSTAR Medical
Last refreshed: 3 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04517786.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing